Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SWTX | SpringWorks Therapeutics, Inc. | Chief Executive Officer, Director | $44.7M | -$3.94M | -8.1% | Sep 3, 2024 |
SPRY | ARS Pharmaceuticals, Inc. | Director | Jun 20, 2024 | |||
PASG | Passage BIO, Inc. | Director | May 21, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|